We insist on innovative research and development to help the development of China’s smart manufacturing; focus on the integration of diagnosis and treatment to nurture cancer and overcome hope; concentrate on precision medicine, Customize patient-specific therapy. The company takes disease biological mechanisms and clinical translational medicine as its core, and conducts in-depth research on tumor signaling pathways, The latest biological mechanisms in the fields of tumor immune microenvironment and immune regulation, and have global independent intellectual property rights. Based on the world’s leading technical standards, Excellent quality control capabilities and a modern, collaborative and efficient supply chain system, Continue to explore and innovate to promote the in-depth development of a new generation of tumor treatment technology to make cancer treatment more efficient, precise and convenient.